Kirby Daniel Gordon 4

4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Feb 12, 2026

AI-generated summary of this filing

Updated Feb 12, 2026

IOVANCE (IOVA) CCO Daniel Gordon Receives RSUs; Shares Withheld

What Happened

Daniel Gordon, Chief Commercial Officer of Iovance Biotherapeutics (IOVA), had 39,996 restricted stock units (RSUs) vest on February 10, 2026. The RSUs converted to common stock (exercise/conversion of derivative).
To satisfy mandatory tax withholding, 16,450 shares were withheld by the issuer at an implied value of $2.60 per share (total value withheld $42,770). After withholding, Gordon received a net 23,546 shares.
This was a vesting/conversion and tax-withholding transaction — not an open-market sale or a cash purchase.

Key Details

Transaction date: 2026-02-10; Form 4 filed 2026-02-12 (appears timely).
RSUs converted: 39,996 shares; shares withheld for taxes: 16,450 @ $2.60 = $42,770; net shares delivered: 23,546.
Codes: M = exercise/conversion of derivative (RSU vesting); F = shares withheld to satisfy tax liability (not an open-market sale).
Footnotes: each RSU equals one share; remaining RSUs from the Feb 10, 2025 grant will vest in equal quarterly installments; the withheld shares reflect mandatory tax withholding, not a sale.

Context

This is a routine executive compensation event (vesting of RSUs) rather than a purchase or deliberate sale. Share withholding for taxes is common and does not imply market selling by the insider.
For retail investors, purchases or open-market insider buys are generally more informative about conviction; this filing documents issuance and withholding arising from compensation.

Form 4

Period: 2026-02-10

Chief Commercial Officer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-10+39,996→ 69,996 total
Tax Payment
Common Stock
[F2][F3]
2026-02-10$2.60/sh−16,450$42,770→ 53,546 total
Exercise/Conversion
Restricted Stock Units
[F4][F5][F6]
2026-02-10−39,996→ 80,004 total
→ Common Stock (39,996 underlying)

Footnotes (6)

[F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
[F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
[F3]Represents the common stock remaining after deducting the common stock withheld for taxes.
[F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
[F5]The remaining RSUs will vest in equal quarterly installments.
[F6]Such aggregate number reflects the remainder of such RSUs granted on February 10, 2025, but does not include any other RSUs held by such Reporting Person.

Signature

/s/ Daniel Gordon Kirby|2026-02-12

1 file